Astilbin, a flavonoid compound, has shown protective effects in DKD by reversing high glucose (HG)-induced autophagy inhibition and regulating the PI3K/Akt pathway to reduce autophagy and apoptosis in HK-2 cells (Chen et al., 2018). This evidence concerns the gene AKT1 and diabetic kidney disease.